Objectif Breakthrough gene expression search engine for cost reduction and significantly increased use of open data in drug discovery. We are putting the power of genetic data analytics into the cloud and providing this as an easy to access service to biologists via a search engine. The challenge today is that as the field of sequencing is developing at a rapid pace and the amount of genetic data is exploding, nobody really can analyze all that data and pull it up when needed for making informed decision in the field of drug development and life science research. We are seizing this business opportunity through our competitive edge by creating an easily usable cloud-based gene expression search engine on top of publicly available datasets that have been analyzed and indexed by our advanced algorithms. This allows for providing unexpected discoveries in the field of drug discovery at a significantly reduced rate and insight, which has not been possible before. Champ scientifique medical and health sciencesbasic medicinepharmacology and pharmacydrug discovery Programme(s) H2020-EU.2.1.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT) Main Programme H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument Thème(s) ICT-37-2014-1 - Open Disruptive Innovation Scheme (implemented through the SME instrument) Appel à propositions H2020-SMEInst-2014-2015 Voir d’autres projets de cet appel Sous appel H2020-SMEINST-1-2014 Régime de financement SME-1 - SME instrument phase 1 Coordinateur MEDICAL TECHNOLOGY GROUP OU Contribution nette de l'UE € 50 000,00 Adresse Ravala 8 10143 Tallinn Estonie Voir sur la carte PME L’entreprise s’est définie comme une PME (petite et moyenne entreprise) au moment de la signature de la convention de subvention. Oui Région Eesti Eesti Põhja-Eesti Type d’activité Private for-profit entities (excluding Higher or Secondary Education Establishments) Liens Contacter l’organisation Opens in new window Participation aux programmes de R&I de l'UE Opens in new window Réseau de collaboration HORIZON Opens in new window Coût total € 71 429,00